3D Printed Drugs Market to Reach US$ 84.14 Billion by 2033, Growing at a CAGR of 10.82%
3D printed drugs are pharmaceutical products manufactured using additive manufacturing technologies that build dosage forms layer by layer. This innovative process enables precise control over drug composition, dosage strength, release profiles, and tablet geometry. Unlike conventional mass-production methods, 3D printing allows the development of customized medications tailored to individual...
0 Комментарии 0 Поделились 108 Просмотры 0 предпросмотр